Table 1.
Control | 1% Tob | 2% Tob | 4% Tob | |
---|---|---|---|---|
sTNF Rll | ++ | + | +/− | +/− |
IGFBP3 | − | − | − | + |
uPAR | − | − | − | + |
Angiogenin | − | − | − | − |
GCSF | − | − | − | − |
RANTES | +/− | +/− | +/− | +/− |
GRO | − | − | +/− | + |
IL-1ra | + | + | ++ | ++ |
bFGF | − | − | + | + |
MIP-1a | + | + | + | + |
ICAM-1 | − | − | − | + |
Osteoprotegerin | − | + | + | + |
IGFBP4 | + | ++ | +++ | ++ |
IL-6 | + | + | + | +++ |
MCP-1 | +/− | + | ++ | ++ |
TIMP-1 | + | ++ | ++ | ++ |
IL-8 | +/− | ++ | ++ | ++ |
TIMP-2 | + | +++ | +++ | +++ |
NOTE: Secreted proteins significantly up-regulated by Tob are designated +, ++, or +++ (also indicated by progressively darker shading), whereas proteins showing little or no change are designated +/− or −.